Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

In an age where celebs own tequila brands, this one owns a hangover cure

  • In News
  • May 18, 2022
  • Samantha Freidin
In an age where celebs own tequila brands, this one owns a hangover cure

We often underestimate the business prowess of influencers and actors, but they do a hell of a lot more than just look pretty. One of those celebs is Shay Mitchell who you may recognise as Emily Fields from Pretty Little Liars, or more recently, as Peach Sallinger in the Netflix series You.

Mitchell has garnered 33 million Instagram followers and millions more on her YouTube, TikTok and Twitter feeds. The actor turned influencer has to be credited for her business acumen, having launched a luggage brand and of course, a tequila brand (as modern day celebs are wont to do). Now, Mitchell is touting the ultimate hangover recovery to pack in your Béis bag alongside your Onda tequila: Hydralyte.

Yep, The Hydration Pharmaceuticals Company (ASX: HPC) who make and distribute Hydralyte have signed a partnership with Shay Mitchell to become a brand ambassador. The partnership will see the actress attend events, promote the product on her social media channels and consult on the Company’s own social media strategy. The Company has also worked with Mitchell to create a new flavour “specifically designed for the actress.”

As an equity partner in the Company, Mitchell has a vested interest worth USD $500,000 in HPC shares.

“Between meetings, working out and chasing a toddler, I don’t drink as much water as I should,” said Mitchell. “I invested in Hydralyte because it delivers superior rapid rehydration, tastes great and is low in sugar so my family gets the hydration they need. It’s a daily life-hack.”

Hydralyte North America CEO Oliver Baker said: “Shay has a deep connection with her followers where they trust the products she recommends, what she has done with her luggage company, BEIS, is extraordinary. As one of the most high profile pregnant women on the planet, she connects directly with our core target market of young families with kids. Her first of many posts begins the intimate story-telling with her audience that allows an authentic introduction of our product’s benefits, ahead of a more consolidated marketing campaign planned for Q3.

“We have timed the launch with Shay to ensure that Hydralyte continues to build strong brand awareness coming into the North American summer period. Traditionally, this period is very high volume and we anticipate increased revenue and cash collection over the coming months.”

For Q1 FY22, the Company reported strong revenue growth of 119% to $1.9 million. Their gross margin increased to 50% from 43% during the last quarter. The Company reported $8.8 million in cash, giving a cash runway of just over four quarters. Product development is progressing on 13 different products and new product launches are expected in the coming months.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • asx hpc
  • hpc
  • hydralyte
  • hydration pharmaceuticals company
  • oliver baker
  • shay mitchell
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.